Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. April 16, 2018. Jeffrey Shapiro.

Executive Summary

Check out what attorney Jeffrey Shapiro had to say about US FDA's recent draft guidance laying out an alternative 510(k) route that bypasses predicate comparisons.

"I think they are addressing a real issue in trying to improve the abbreviated 510(k) process, but it's not a silver bullet that will dramatically improve the effectiveness of the 510(k) process across the board." – Jeffrey Shapiro, director, Hyman, Phelps & McNamara

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts